Verve Therapeutics has started dosing patients in a phase 1b trial of its in vivo gene-editing drug for high cholesterol, designed to permanently switch off the PCSK9 gene with a one-shot treatment.
Aug. 14, 2024 — More than a quarter of Australians over the age of 50 take cholesterol-lowering drugs to prevent heart disease and strokes, but our bodies also need cholesterol to survive.
Being proactive is the best thing you can do for ... so there’s no excuse from availability of medications and lifestyle modifications. Know your cholesterol,” he said. Whether you make ...
The researchers hope the breakthrough will help scientists cure a genetic disorder that increases the likelihood of dying from coronary artery disease at a young age.
I am a healthy 84-year-old who exercises regularly, eats meat and dairy sparingly, doesn’t smoke, and has a BMI about 25. (I’m 6 feet, 1 inch tall, at ...
JE: Human genetic studies provide strong target validation for the role of PCSK9 in modulating LDL cholesterol (LDL-C) levels and the risk of coronary heart disease (CHD).